Author: Disparity Matters

Research published in Science Advances reveals that specific components of fine particulate matter drive profound racial and ethnic disparities in cardiovascular deaths across the United States. The study analyzed data from over 3,100 counties spanning two decades, finding that cardiovascular deaths linked to air pollution components dropped from 42,200 in 2001 to 23,500 in 2020, primarily due to reductions in ammonium and sulfate pollution.However, these improvements have not benefited all communities equally. Non-Hispanic Black and Hispanic populations experienced significantly slower declines in attributable deaths compared with non-Hispanic white populations. Between 2001 and 2020, the relative disparity in deaths increased by…

Read More

Nearly half of all American adults will be living with obesity by 2035, but the burden falls heaviest on Black women, who face obesity rates approaching 57 percent, according to new national projections published in JAMA.The analysis found that 42.5 percent of U.S. adults were living with obesity in 2022, up sharply from 19.3 percent in 1990. That translates to 107 million Americans currently affected, a number expected to climb to 126 million within the next decade.Racial disparities in obesity prevalence are substantial and persistent. In 2022, obesity rates by race, ethnicity, and sex ranged from 40.1 percent for non-Hispanic…

Read More

Maternal syphilis rates surged 28% nationwide between 2022 and 2024, with stark racial disparities revealing a public health crisis that disproportionately affects minority communities. Data from the National Center for Health Statistics shows rates climbed from 280.4 to 357.9 cases per 100,000 births during this period.American Indian and Alaska Native mothers face the most severe burden, with rates skyrocketing 52% to reach 2,145.4 per 100,000 births in 2024. This figure is more than eleven times higher than the rate among White non-Hispanic mothers, which stood at 188.2 per 100,000 births.Black non-Hispanic mothers experienced a 30% increase, with rates rising to…

Read More

A landmark breast cancer drug trial that led to FDA approval enrolled only 0.6% Black patients, raising serious concerns about racial disparities in medical research. The Phase 3 study testing inavolisib, a breakthrough treatment for hormone receptor-positive breast cancer, included more men than Black women despite Black women having a 40% higher death rate from breast cancer than white women.Medical oncologist Yehoda Martei from the University of Pennsylvania warns this pattern represents both a moral and scientific failure. Recent therapeutic trials show a troubling trend of declining Black patient enrollment. While the ASCENT trial for metastatic triple-negative breast cancer enrolled…

Read More

Routine experiences of discrimination leave lasting marks on the immune system, causing white blood cells to become exhausted and less effective at fighting disease, according to new research from NYU School of Global Public Health. The study reveals a biological pathway through which social inequities contribute to health disparities affecting minority communities.Researchers examined blood samples and surveys from 6,337 adults aged 50 and older, asking participants about everyday discrimination experiences such as being treated with less respect, perceived as unintelligent, or receiving inferior service in restaurants and medical settings. These encounters could stem from race, gender, economic status, or other…

Read More

Black Medicaid patients newly diagnosed with opioid use disorder wait months longer than white patients to receive life-saving medications, according to a national study analyzing records from nearly 1.2 million enrollees across 44 states. Black patients were about one-third less likely than white patients to receive methadone or other medications to treat opioid use disorder. Researchers found that Medicaid patients can wait up to six months to begin treatment, despite medical consensus that people with opioid use disorder should receive medication as quickly as possible. Between 27% and 34% of patients received medication within six months of diagnosis, meaning nearly…

Read More

A longitudinal study tracking over 1,500 St Louis adults reveals that cumulative lifetime stress and chronic inflammation explain nearly half of the mortality differences between Black and White populations. Researchers found Black participants had significantly shorter survival times, with 25.3% dying during the study period compared to 11.9% of White participants.The research examined multiple stress factors including childhood maltreatment, lifetime trauma, discrimination experiences, and socioeconomic indicators. Black participants reported substantially higher cumulative stress levels and showed elevated inflammatory markers, specifically C-reactive protein and interleukin-6 measured in blood samples. These biological differences accounted for 49.3% of the increased mortality risk among…

Read More

Thyroid cancer has more than tripled in incidence over recent decades, becoming one of the fastest growing cancers in the United States. Yet behind this alarming trend lies a troubling paradox that reveals deep racial inequities in American healthcare.Black Americans develop thyroid cancer at rates 40-50% lower than other racial and ethnic groups. Despite this lower prevalence, they face more advanced disease at diagnosis, receive inferior treatment, and die at higher rates. African Americans also face elevated risk for anaplastic thyroid cancer, an aggressive and often fatal form that grows rapidly with poor prognosis.Treatment disparities compound these survival differences. Black…

Read More